Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

International Rett syndrome study: InterRett

Helen Jenny Leonard Downs MBChB MPH BApplSci (physio) MSc PhD Principal Research Fellow Head, Child Disability +61 419 956 946 08 6319 1763

Research

Kumaparniku Initiative

In the Kariyarra language of the traditional owners of Port Hedland, Kumaparniku means ‘all together in one’. Over the next couple of years, we will be conducting some research that will look at how we can work together to grow up strong healthy babies and kids.

Frequently Asked Questions

Some of the more common questions about the LiLO study

Research

Molecular Detection of Scabies by PCR Using a Next Generation Sequencing (NGS) Approach

In recent years, the interest in molecular diagnostic methods for the detection of many pathogens has grown substantially.

Research

Multi-site validation of a suite of clinical outcome measures for clinical trial readiness in the CDKL5 Deficiency Disorder

Helen Jenny Peter Leonard Downs Jacoby MBChB MPH BApplSci (physio) MSc PhD BA (Hons) MSc Principal Research Fellow Head, Child Disability

Research

BENEFIT - Breastfeeding and Eating Nuts and Eggs For Infant Tolerance Trial

Debbie Susan Palmer Prescott BSc BND PhD MBBS BMedSci PhD FRACP Head, Nutrition in Early Life Honorary Research Fellow debbie.palmer@uwa.edu.au

Research

National School Readiness Project

Researchers at the Institute were engaged to undertake the National School Readiness Project, which aimed to describe current practice across education authorities in assessing or describing child development status at school entry and use evidence to identify areas where the scope/quality of curren

Research

iPLAYCE Study

Hayley Christian BSc (1st Class Hons), PhD W.Aust. Head, Child Physical Activity, Health and Development; National Heart Foundation Future Leader

Research

Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in Healthy Preterm Infants

Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical